| - GRCh37:
- Chr1:179544864-179544865
- GRCh38:
- Chr1:179575729-179575730
| NPHS2 | S46fs | Nephrotic syndrome, type 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr1:179521804
- GRCh38:
- Chr1:179552669
| NPHS2, AXDND1 | R201S, R269S | Nephrotic syndrome, type 2 | Uncertain significance (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179530462-179530465
- GRCh38:
- Chr1:179561327-179561330
| NPHS2 | F137fs | Nephrotic syndrome, type 2 | Likely pathogenic (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179528821-179528823
- GRCh38:
- Chr1:179559686-179559688
| NPHS2 | F176fs | Nephrotic syndrome, type 2 | Likely pathogenic (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544756
- GRCh38:
- Chr1:179575621
| NPHS2 | A82fs | Nephrotic syndrome, type 2 | Likely pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179526264-179526265
- GRCh38:
- Chr1:179557129-179557130
| NPHS2 | K212fs | Nephrotic syndrome, type 2 | Likely pathogenic (Dec 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179523621
- GRCh38:
- Chr1:179554486
| AXDND1, NPHS2 | R194*, R262* | Nephrotic syndrome, type 2 | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179530482
- GRCh38:
- Chr1:179561347
| NPHS2 | Y131* | Nephrotic syndrome, type 2 | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179528819-179528820
- GRCh38:
- Chr1:179559684-179559685
| NPHS2 | F176fs | Nephrotic syndrome, type 2 | Likely pathogenic (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179533851
- GRCh38:
- Chr1:179564716
| NPHS2 | P118S | Nephrotic syndrome, type 2 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179528801
- GRCh38:
- Chr1:179559666
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Likely benign (Sep 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179520532
- GRCh38:
- Chr1:179551397
| AXDND1, NPHS2 | E242K, E310K | Idiopathic nephrotic syndrome, Nephrotic syndrome, type 2, not provided
| Likely pathogenic (Mar 10, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179528842
- GRCh38:
- Chr1:179559707
| NPHS2 | L169P | Idiopathic nephrotic syndrome, not provided, Nephrotic syndrome, type 2
| Pathogenic (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179528809
- GRCh38:
- Chr1:179559674
| NPHS2 | | Nephrotic syndrome, type 2, not provided | Uncertain significance (Oct 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179530478
- GRCh38:
- Chr1:179561343
| NPHS2 | R133fs | Nephrotic syndrome, type 2, not provided | Pathogenic (Jan 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544999
- GRCh38:
- Chr1:179575864
| NPHS2 | M1L | Nephrotic syndrome, type 2 | Pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179528942
- GRCh38:
- Chr1:179559807
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Benign (Jul 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179528917
- GRCh38:
- Chr1:179559782
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Benign (Jul 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179545115
- GRCh38:
- Chr1:179575980
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179533927
- GRCh38:
- Chr1:179564792
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Likely benign (Jul 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544862
- GRCh38:
- Chr1:179575727
| NPHS2 | | Nephrotic syndrome, type 2, not provided | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544862
- GRCh38:
- Chr1:179575727
| NPHS2 | | Nephrotic syndrome, type 2, not provided | Conflicting interpretations of pathogenicity (Feb 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179526353
- GRCh38:
- Chr1:179557218
| NPHS2 | D183Y | Nephrotic syndrome, type 2 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520428
- GRCh38:
- Chr1:179551293
| AXDND1, NPHS2 | F276fs, F344fs | not provided, Nephrotic syndrome, type 2 | Pathogenic/Likely pathogenic (Aug 28, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179528896
- GRCh38:
- Chr1:179559761
| NPHS2 | | Nephrotic syndrome, type 2, not provided | Pathogenic/Likely pathogenic (Feb 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179526339
- GRCh38:
- Chr1:179557204
| NPHS2 | M187I | not provided, not specified, Nephrotic syndrome, type 2
| Conflicting interpretations of pathogenicity (Feb 17, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179520537
- GRCh38:
- Chr1:179551402
| AXDND1, NPHS2 | A240V, A308V | Nephrotic syndrome, type 2 | Likely pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520505-179520507
- GRCh38:
- Chr1:179551370-179551372
| AXDND1, NPHS2 | A250del, A318del | Nephrotic syndrome, type 2 | Likely pathogenic (Feb 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179530439
- GRCh38:
- Chr1:179561304
| NPHS2 | R146fs | not provided, Nephrotic syndrome, type 2 | Pathogenic (Feb 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179526161
- GRCh38:
- Chr1:179557026
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Pathogenic/Likely pathogenic (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179530456
- GRCh38:
- Chr1:179561321
| NPHS2 | G140fs | Nephrotic syndrome, type 2, not provided | Pathogenic (Dec 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544741
- GRCh38:
- Chr1:179575606
| NPHS2 | E87* | Nephrotic syndrome, type 2 | Pathogenic (Oct 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179523640
- GRCh38:
- Chr1:179554505
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2, not provided | Conflicting interpretations of pathogenicity (Mar 7, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179521727
- GRCh38:
- Chr1:179552592
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2, not provided | Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179520585
- GRCh38:
- Chr1:179551450
| AXDND1, NPHS2 | M224T, M292T | Nephrotic syndrome, type 2 | Uncertain significance (Mar 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544983
- GRCh38:
- Chr1:179575848
| NPHS2 | R6Q | not provided, Nephrotic syndrome, type 2 | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179520182
- GRCh38:
- Chr1:179551047
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520181
- GRCh38:
- Chr1:179551046
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2 | Uncertain significance (Feb 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520109
- GRCh38:
- Chr1:179550974
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544880
- GRCh38:
- Chr1:179575745
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179544780
- GRCh38:
- Chr1:179575645
| NPHS2 | G74S | not provided, Nephrotic syndrome, type 2 | Uncertain significance (May 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179530409
- GRCh38:
- Chr1:179561274
| NPHS2 | | Nephrotic syndrome, type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179519886
- GRCh38:
- Chr1:179550751
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179530496
- GRCh38:
- Chr1:179561361
| NPHS2 | V127I | Nephrotic syndrome, type 2 | Likely pathogenic (Apr 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179526323-179526324
- GRCh38:
- Chr1:179557188-179557189
| NPHS2 | I192fs | Nephrotic syndrome, type 2 | Pathogenic (May 8, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520479
- GRCh38:
- Chr1:179551344
| AXDND1, NPHS2 | Q260fs, Q328fs | Nephrotic syndrome, type 2 | Pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520575
- GRCh38:
- Chr1:179551440
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2, not provided | Likely benign (Oct 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179526290
- GRCh38:
- Chr1:179557155
| NPHS2 | | Nephrotic syndrome, type 2, not provided | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179544856
- GRCh38:
- Chr1:179575721
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179526177
- GRCh38:
- Chr1:179557042
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Likely benign (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179520531
- GRCh38:
- Chr1:179551396
| NPHS2, AXDND1 | E310V, E242V | Nephrotic syndrome, type 2 | Pathogenic (Nov 21, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr1:179521787-179521788
- GRCh38:
- Chr1:179552652-179552653
| AXDND1, NPHS2 | Q275fs, Q207fs | Nephrotic syndrome, type 2 | Pathogenic (Jan 17, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr1:179544833
- GRCh38:
- Chr1:179575698
| NPHS2 | E56fs | Nephrotic syndrome, type 2 | Likely pathogenic (May 17, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr1:179528869
- GRCh38:
- Chr1:179559734
| NPHS2 | D160V | Nephrotic syndrome, type 2 | Likely pathogenic (May 17, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr1:179526191
- GRCh38:
- Chr1:179557056
| NPHS2 | E237Q | not provided, Nephrotic syndrome, type 2, Focal segmental glomerulosclerosis, not specified | Conflicting interpretations of pathogenicity (Oct 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179530428
- GRCh38:
- Chr1:179561293
| NPHS2 | | not specified, not provided, Nephrotic syndrome, type 2
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179520396
- GRCh38:
- Chr1:179551261
| AXDND1, NPHS2 | N355S, N287S | not provided, Nephrotic syndrome, type 2 | Uncertain significance (May 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179521760
- GRCh38:
- Chr1:179552625
| AXDND1, NPHS2 | A284V, A216V | not provided, Nephrotic syndrome, type 2, Idiopathic nephrotic syndrome
| Pathogenic/Likely pathogenic (Oct 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179520326-179520331
- GRCh38:
- Chr1:179551191-179551196
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2 | Uncertain significance (May 25, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520437-179520448
- GRCh38:
- Chr1:179551302-179551313
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2 | Uncertain significance (May 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179533930
- GRCh38:
- Chr1:179564795
| NPHS2 | | Nephrotic syndrome, type 2 | Likely pathogenic (Apr 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179533831
- GRCh38:
- Chr1:179564696
| NPHS2 | C124W | Nephrotic syndrome, type 2 | Uncertain significance (Apr 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544751
- GRCh38:
- Chr1:179575616
| NPHS2 | L84fs | Nephrotic syndrome, type 2 | Likely pathogenic (Apr 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544833-179544834
- GRCh38:
- Chr1:179575698-179575699
| NPHS2 | E56fs | Nephrotic syndrome, type 2 | Likely pathogenic (Mar 21, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179528880-179528881
- GRCh38:
- Chr1:179559745-179559746
| NPHS2 | L156fs | Nephrotic syndrome, type 2, not provided | Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179530401-179530402
- GRCh38:
- Chr1:179561266-179561267
| NPHS2 | | Nephrotic syndrome, type 2 | Likely benign (Feb 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179526186
- GRCh38:
- Chr1:179557051
| NPHS2 | R238S | not provided, Focal segmental glomerulosclerosis, Nephrotic syndrome, type 2
| Pathogenic/Likely pathogenic (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179520481
- GRCh38:
- Chr1:179551346
| AXDND1, NPHS2 | L327F, L259F | not provided, Nephrotic syndrome, type 2 | Conflicting interpretations of pathogenicity (Mar 19, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179521749
- GRCh38:
- Chr1:179552614
| AXDND1, NPHS2 | A288T, A220T | Nephrotic syndrome, type 2, not provided | Conflicting interpretations of pathogenicity (May 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179526205
- GRCh38:
- Chr1:179557070
| NPHS2 | T232I | Nephrotic syndrome, type 2 | Uncertain significance (Mar 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179521739
- GRCh38:
- Chr1:179552604
| AXDND1, NPHS2 | R291Q, R223Q | not specified, Nephrotic syndrome, type 2 | Uncertain significance (Jan 31, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544912
- GRCh38:
- Chr1:179575777
| NPHS2 | E30K | Nephrotic syndrome, type 2 | Uncertain significance (Jan 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520495
- GRCh38:
- Chr1:179551360
| NPHS2, AXDND1 | R322Q, R254Q | Nephrotic syndrome, type 2 | Uncertain significance (May 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179526229
- GRCh38:
- Chr1:179557094
| NPHS2 | R224H | Nephrotic syndrome, type 2 | Uncertain significance (May 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544804-179544806
- GRCh38:
- Chr1:179575669-179575671
| NPHS2 | V65del | Nephrotic syndrome, type 2 | Uncertain significance (Dec 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544834
- GRCh38:
- Chr1:179575699
| NPHS2 | E56* | Nephrotic syndrome, type 2 | Likely pathogenic (Dec 5, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179521737
- GRCh38:
- Chr1:179552602
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2 | Likely pathogenic (Dec 5, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179530490
- GRCh38:
- Chr1:179561355
| NPHS2 | Q129* | Nephrotic syndrome, type 2 | Pathogenic (Nov 12, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179526269
- GRCh38:
- Chr1:179557134
| NPHS2 | S211T | Nephrotic syndrome, type 2 | Uncertain significance (Sep 26, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179526160
- GRCh38:
- Chr1:179557025
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Pathogenic/Likely pathogenic (Aug 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179528825
- GRCh38:
- Chr1:179559690
| NPHS2 | P175S | Nephrotic syndrome, type 2 | Uncertain significance (Aug 22, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544915
- GRCh38:
- Chr1:179575780
| NPHS2 | A29T | Nephrotic syndrome, type 2 | Uncertain significance (Dec 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179533824
- GRCh38:
- Chr1:179564689
| NPHS2 | | not provided, Nephrotic syndrome, type 2 | Pathogenic (Sep 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179520587
- GRCh38:
- Chr1:179551452
| AXDND1, NPHS2 | | not provided, Nephrotic syndrome, type 2 | Pathogenic/Likely pathogenic (Mar 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179521736
- GRCh38:
- Chr1:179552601
| AXDND1, NPHS2 | | not provided, Nephrotic syndrome, type 2 | Pathogenic/Likely pathogenic (Aug 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179520588
- GRCh38:
- Chr1:179551453
| AXDND1, NPHS2 | | not provided, Nephrotic syndrome, type 2 | Pathogenic/Likely pathogenic (Oct 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544988-179544990
- GRCh38:
- Chr1:179575853-179575855
| NPHS2 | R4del | Nephrotic syndrome, type 2 | Uncertain significance (Jun 23, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179520526
- GRCh38:
- Chr1:179551391
| NPHS2, AXDND1 | L312V, L244V | Nephrotic syndrome, type 2 | Uncertain significance (May 10, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544931-179544933
- GRCh38:
- Chr1:179575796-179575798
| NPHS2 | E23del | Nephrotic syndrome, type 2 | Uncertain significance (May 8, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179523635
- GRCh38:
- Chr1:179554500
| NPHS2, AXDND1 | G257E, G189E | Nephrotic syndrome, type 2 | Uncertain significance (Apr 10, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544898
- GRCh38:
- Chr1:179575763
| NPHS2 | R36fs | Nephrotic syndrome, type 2 | Likely pathogenic (Mar 10, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179544876
- GRCh38:
- Chr1:179575741
| NPHS2 | G42R | Nephrotic syndrome, type 2, not provided | Benign/Likely benign (Sep 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179521828
- GRCh38:
- Chr1:179552693
| AXDND1, NPHS2 | | Nephrotic syndrome, type 2 | Uncertain significance (Dec 27, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr1:179526278
- GRCh38:
- Chr1:179557143
| NPHS2 | A208T | Nephrotic syndrome, type 2, not specified, not provided
| Uncertain significance (Mar 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544789
- GRCh38:
- Chr1:179575654
| NPHS2 | R71* | Nephrotic syndrome, type 2 | Pathogenic (Jul 8, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179526366
- GRCh38:
- Chr1:179557231
| NPHS2 | | Idiopathic nephrotic syndrome, Familial idiopathic steroid-resistant nephrotic syndrome, Nephrotic syndrome, type 2
| Pathogenic/Likely pathogenic (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179544844
- GRCh38:
- Chr1:179575709
| NPHS2 | T53fs | Nephrotic syndrome, type 2, not provided | Pathogenic/Likely pathogenic (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:179523615
- GRCh38:
- Chr1:179554480
| AXDND1, NPHS2 | E264Q, E196Q | not provided, not specified, Nephrotic syndrome, type 2
| Conflicting interpretations of pathogenicity (Oct 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179523626
- GRCh38:
- Chr1:179554491
| AXDND1, NPHS2 | V260E, V192E | not provided, Nephrotic syndrome, type 2 | Conflicting interpretations of pathogenicity (Sep 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:179544895-179544896
- GRCh38:
- Chr1:179575760-179575761
| NPHS2 | R36fs | not provided, Nephrotic syndrome, type 2 | Pathogenic (Sep 12, 2021) | criteria provided, multiple submitters, no conflicts |